TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.10$ +1.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow XLO
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – -289.7% -11.4%
– – – – – 25.9% 3.5%
– – – – – 101.4% 15.9%
– – – – – 501.0% 57.4%
– – – – – 0.6% 1.2%
– – – – – -0.6% -1.2%
– – – – – – 6.4%
– – – – – -53.3% 0.0%
– – – – – 460.2% 200.6%
– – – – – 170.0% 188.0%
– – – – – -290.3% -12.6%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?